Selecky Christobel (CIK 1849739) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-06). Recent activity: Buy IBRX (35,064 shares), Buy IBRX (124,414 shares), Sell IBRX (159,478 shares), Buy IBRX (32,173 shares), Buy IBRX (33,549 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | ImmunityBio, Inc. (IBRX) | Director | Buy | 35,064 | $104,491 |
| 2026-07-06 | ImmunityBio, Inc. (IBRX) | Director | Buy | 124,414 | $371,998 |
| 2026-07-06 | ImmunityBio, Inc. (IBRX) | Director | Sell | 159,478 | $1.4M |
| 2026-07-01 | ImmunityBio, Inc. (IBRX) | Director | Buy | 32,173 | $95,876 |
| 2026-07-01 | ImmunityBio, Inc. (IBRX) | Director | Buy | 33,549 | $100,312 |
| 2026-07-01 | ImmunityBio, Inc. (IBRX) | Director | Buy | 30,000 | $85,200 |
| 2026-07-01 | ImmunityBio, Inc. (IBRX) | Director | Sell | 95,722 | $862,216 |
| 2026-07-01 | ImmunityBio, Inc. (IBRX) | Director | Buy | 700 | $2,086 |
| 2026-07-01 | ImmunityBio, Inc. (IBRX) | Director | Buy | 300 | $897 |
| 2026-07-01 | ImmunityBio, Inc. (IBRX) | Director | Sell | 1,000 | $9,000 |
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | Director | Buy | 25,000 | $74,500 |
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | Director | Sell | 25,000 | $250,000 |
| 2026-01-21 | ImmunityBio, Inc. (IBRX) | Director | Buy | 50,000 | $149,000 |
| 2026-01-21 | ImmunityBio, Inc. (IBRX) | Director | Sell | 50,000 | $250,000 |
| 2026-01-21 | ImmunityBio, Inc. (IBRX) | Director | Buy | 25,000 | $74,500 |
| 2026-01-21 | ImmunityBio, Inc. (IBRX) | Director | Sell | 25,000 | $187,750 |
Source: SEC Form 4 filings · as of 2026-07-06